[ MATURITY LEVEL 3 OF 5 ]

Level 3: Managed

Structured, proactive, inspection-ready.

You run a structured, inspection-ready quality system. To advance, instrument your processes with metrics and trending so decisions are evidenced by data rather than judgement alone.

What a level is not

The five levels are SPEQ’s progression, labelled synthesis. They are not the FDA’s Quality Management Maturity rating scale, no regulator assigns them, and reaching one is not a compliance status.

1
Foundational
2
Defined
3
Managed
4
Quantified
5
Optimized
[ WHAT LEVEL 3 LOOKS LIKE, DOMAIN BY DOMAIN ]

A quality system rarely sits at one level everywhere. This is the character of each of the twelve GxP domains when it is operating at Level 3 — and the move that lifts it to the next.

Documentation & Change Control

Formal change control with real impact assessment and approval before implementation; documents are reliably current.

TO ADVANCE →Instrument the system — trend change volume, lead time, and overdue actions so management review acts on data.

Risk Management & CAPA

Root cause is taken seriously, effectiveness checks are real, and risk decides investigation depth (ICH Q9).

TO ADVANCE →Trend CAPA metrics and feed them to management review so the system is steered by data.

Validation & Qualification

A risk- and science-based V&Q lifecycle is in place; the control strategy is understood and maintained.

TO ADVANCE →Instrument the process — trend Cpk and CPV so drift is seen before a batch fails.

Environmental Monitoring

A risk-based EM program feeds a contamination control strategy; excursions are investigated in context.

TO ADVANCE →Trend EM data so shifts in the state of control are detected before an excursion.

Regulatory Intelligence

Systematic horizon scanning feeds a defined impact-assessment and action process.

TO ADVANCE →Move from reacting to changes to proactively gap-analysing against upcoming requirements.

Clinical Quality (GCP)

Risk-based quality management (RBQM) focuses oversight on critical-to-quality factors.

TO ADVANCE →Add centralised/statistical monitoring so signals are detected across sites, not one visit at a time.

Nonclinical & Laboratory (GLP)

A compliant GLP system runs with independent QA and controlled archives.

TO ADVANCE →Trend QA findings and laboratory data so systemic issues surface across studies.

Distribution & Cold Chain (GDP)

Qualified lanes and containers with monitored conditions; excursions are assessed against defined criteria.

TO ADVANCE →Trend excursion and lane performance so weak links are fixed before they fail.

Pharmacovigilance (GVP)

Systematic signal management runs alongside compliant case processing and a current PSMF.

TO ADVANCE →Add signal and safety metrics so benefit-risk is managed proactively.

Data Integrity

ALCOA+ controls are in place across critical systems with routine, risk-based audit-trail review.

TO ADVANCE →Trend audit-trail-review findings and data-integrity events so systemic weaknesses surface.

Engineering & Commissioning (GEP)

Science- and risk-based C&Q focuses verification on what affects product and patient.

TO ADVANCE →Trend verification and system-reliability data so engineering learns across projects.

Quality Culture & Empowerment

It is observably safe to raise problems; stop-the-line authority is real and Just Culture is applied.

TO ADVANCE →Measure the culture — track speak-up rates and near-miss reporting so leaders steer it with data.